New DNA ‘Fingerprint’ Test Predicts Response To Toxic Breast Cancer Drugs

Scientists have developed a new genetic fingerprint test which aims to identify women with breast cancer who are likely to respond to a class of often-useful, but toxic chemotherapy agents including one commonly referred to as " the red devil " by patients and survivors.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news